Related by context. All words. (Click for frequent words.) 73 SNT MC# 69 YONDELIS 69 Aviptadil 68 Raptiva R 68 thetreatment 68 Evoltra ® 67 Certican 67 TEMODAL 67 Panzem R 67 Aryplase 67 YONDELIS R 66 IMiDs ® compound 66 Mepact 66 receptor tyrosine kinase inhibitor 66 orphan designation 66 octreotide implant 66 Fibrillex TM 66 Orphan Medicinal Product 66 orphan medicinal product 65 TRO# 65 sorafenib tablets 65 BCR ABL inhibitor 65 Amrubicin 65 IL# PE#QQR 65 rilonacept 65 Trobalt 65 Vidaza azacitidine 65 Personalized Immunotherapy 65 PHX# 65 MAGE A3 ASCI 65 OMP designation 65 Friedreich Ataxia FRDA 65 dihydrochloride 65 MERREM 65 Belimumab 65 Orphan designation 65 acyclovir Lauriad R 65 Vimpat R 65 GW# [003] 65 hoFH 65 IAP inhibitor 65 Simulect 65 thalidomide Thalomid 65 MAA submission 65 myelodysplastic myeloproliferative diseases 65 Preotact 65 R sorafenib tablets 65 Tasimelteon 64 RhuDex 64 Nexavar sorafenib 64 IV Busulfex 64 Zenvia ™ 64 PDE4 inhibitor 64 Lambert Eaton Myasthenic 64 Kepivance 64 Plicera 64 Diamyd ® 64 ospemifene 64 Icatibant 64 antibody MAb 64 INSPIRE Trial Phase III 64 diabetic gastroparesis 64 IMiDs R 64 RhuDex ® 64 PNP inhibitor 64 Orphan Drug status 64 HuMax EGFr 64 Zorbtive TM 64 FIRAZYR 64 ZOLINZA 64 Virulizin ® 64 IgG1 monoclonal antibody 64 Arranon 64 Ranolazine 64 alvespimycin 64 sunitinib malate 64 ELACYT 64 multiple myeloma MM 64 MGd 64 bortezomib Velcade 64 reslizumab 64 methylnaltrexone bromide 64 Troxatyl 64 Serostim ® 64 refractory chronic lymphocytic 64 UVIDEM 64 Aplidin 64 Liprotamase 64 Civacir 64 omacetaxine mepesuccinate 64 idursulfase 64 Tyrima 64 Onconase 64 forodesine 63 Velcade bortezomib 63 orally administered inhibitor 63 Cetrorelix 63 Orphan Drug designations 63 hypereosinophilic syndrome 63 docetaxel Taxotere ® 63 Romiplostim 63 phase IIb trial 63 Azedra 63 IMiDs ® 63 Tarceva TM 63 Ocrelizumab 63 secondary hyperparathyroidism 63 adult chronic ITP 63 Insegia 63 ezogabine 63 volociximab 63 Actimmune ® 63 mertansine 63 SUTENT ® 63 Oracea ® 63 FOLOTYN ® 63 LHRH antagonist 63 Cellegesic 63 targeted radiotherapeutic 63 bazedoxifene 63 Cimzia TM 63 Traficet EN 63 ularitide 63 investigational humanized monoclonal antibody 63 pain palliation 63 Mimpara 63 Cloretazine 63 liver resection surgeries 63 Phenoptin 63 generation purine nucleoside 63 Teysuno 63 Evoltra 63 Xyfid TM 63 Yondelis ® 63 chimeric monoclonal antibody 63 lexidronam injection 63 EP #R 63 aerosolized AAT 63 TYZEKA 63 relapsed MM 63 rheumatoid arthritis psoriatic arthritis 63 CONBRIZA 63 cinacalcet 63 TNF Tumor Necrosis Factor 63 AA amyloidosis 63 Campath ® 63 ACOMPLIA R 63 Dacogen decitabine 63 neratinib 63 Lubiprostone 63 Raptiva ® 63 pouchitis 63 Febuxostat 63 Peginterferon alfa 2b 63 Sycrest 63 cutaneous T 63 elotuzumab 63 silodosin 63 Glybera 63 molecular imaging radiopharmaceutical 63 alefacept 62 PGL# 62 IMA# 62 histamine dihydrochloride 62 Nexavar ® 62 docetaxel Taxotere R 62 Kit CD# positive 62 IBS C 62 HuMax TAC 62 MORAb 62 intranasal formulation 62 liposomal formulation 62 Preotact R 62 severe gastroparesis 62 Syndrome LEMS 62 phase III isavuconazole 62 Torisel 62 rufinamide 62 catheter occlusion 62 Octreolin 62 ORENCIA R 62 RNAi therapeutic targeting 62 pediatric acute lymphoblastic 62 Adenuric R 62 relapsed multiple myeloma 62 oral prodrug 62 rasagiline tablets 62 vidofludimus 62 Onalta 62 FIRMAGON R 62 Solazed 62 PD LID 62 MEK inhibitor 62 oropharyngeal candidiasis 62 beta 1a 62 Serdolect ® 62 Azacitidine 62 Behcet uveitis 62 herpetic keratitis 62 post operative ileus 62 PDX pralatrexate 62 Prestara 62 HQK 62 A1PI 62 ThermoDox R 62 Kuvan R 62 Certolizumab pegol 62 TORISEL 62 humanised monoclonal antibody 62 AZILECT ® 62 immunotherapeutic vaccine 62 HuLuc# 62 metastatic malignant 62 TORISEL TM 62 Esbriet pirfenidone 62 anticancer compound 62 PrevOnco ™ 62 Ophena 62 myelofibrosis polycythemia vera 62 HuMax CD4 62 Dapagliflozin 62 cathepsin K inhibitor 62 Thalidomide Pharmion 62 Firazyr 62 entinostat 62 Acute Myeloid Leukemia AML 62 AEG# 62 RhuDex TM 62 vapreotide acetate 62 acetonide FA 62 TACI Ig 62 Fabry Disease 62 Leukine ® 62 GTC recombinant form 62 PEGylated anti 62 histone deacetylase HDAC inhibitor 62 Evoltra TM 62 Junovan TM 62 selective modulator 62 Vandetanib 62 Exherin TM 62 Annamycin 62 RAPTIVA 62 Noxafil 62 CINTREDEKIN BESUDOTOX 62 Ceflatonin 62 Tanespimycin 62 ADP receptor antagonist 62 INS# [001] 62 sJIA 62 diabetic neuropathic pain 62 Cimzia certolizumab pegol 62 Retacrit 62 Fx #A 62 CHMP recommendation 62 XIAFLEX ™ 62 Fludara ® 62 recurrent glioblastoma multiforme 62 MYLOTARG 62 Sebivo 62 OMP #R# 62 clevidipine 62 SNT-MC#/idebenone 62 TYGACIL 62 #D#C# 62 TKM ApoB 62 Advanced Renal Cell 62 TRISENOX 62 Phase IIIb clinical 62 kidney urologic 62 CIMZIA ® 62 cinacalcet HCl 62 Hervé Hoppenot President 61 selective androgen receptor modulator 61 Cimzia ® certolizumab pegol 61 Targretin capsules 61 GAMMAGARD 61 Xcellerated T Cells 61 HCV protease inhibitor 61 Lixivaptan 61 acadesine 61 sargramostim 61 teplizumab 61 post herpetic neuralgia PHN 61 Clolar ® 61 PANVAC VF 61 etanercept Enbrel 61 PRT# 61 Tavocept 61 trabectedin 61 CEQ# 61 Silodosin 61 relapsing remitting MS RRMS 61 Exforge HCT 61 Granulocyte Colony Stimulating Factor 61 eprodisate KIACTA TM 61 KNS # 61 Squalamine 61 Vidaza R 61 SEBIVO 61 Dacogen injection 61 oral ridaforolimus 61 Increlex ® 61 Myelodysplastic syndromes MDS 61 Proellex TM 61 CTAP# Capsules 61 Prodarsan R 61 mu opioid receptor antagonist 61 atacicept 61 opioid induced constipation OIC 61 Soliris eculizumab 61 vismodegib 61 alvimopan 61 briakinumab 61 Onco TCS 61 adenosine injection 61 histone deacetylase inhibitor 61 Generx ™ 61 vemurafenib 61 CD# CEA 61 hypoparathyroidism 61 Angiox ® 61 dextromethorphan quinidine 61 CDP# 61 Mycamine 61 efalizumab 61 pediatric Crohn disease 61 Nabi HB Intravenous 61 Cethrin 61 Xanafide 61 ALN TTR 61 BENLYSTA ® 61 Zavesca ® 61 levocetirizine 61 small molecule thrombopoietin 61 Egrifta 61 bevacizumab Avastin ® 61 Investigational Treatment 61 SYCREST 61 PDE# inhibitors 61 Panzem 61 Wafer polifeprosan 61 EOquin TM 61 PSMA ADC 61 Pathway Inhibitor 61 BLA submission 61 R Saizen R 61 PSN# [001] 61 Genasense ® 61 AVASTIN 61 Advagraf 61 ATL# [002] 61 humanized interleukin 6 61 placebo controlled Phase III 61 rhFVIIa 61 Methylnaltrexone 61 pseudobulbar affect PBA 61 Dasatinib 61 Virulizin R 61 methylnaltrexone 61 AMEVIVE 61 Desmoteplase 61 PI3K/Akt pathway inhibitor 61 Evoltra R 61 depsipeptide 61 ankylosing spondylitis AS 61 Factor VIIa 61 ARCOXIA 61 Gabapentin GR 61 novel VDA molecule 61 terlipressin 61 MGCD# [001] 61 tamibarotene 61 refractory metastatic colorectal cancer 61 CAELYX 61 homozygous FH 61 Gamunex C 61 ICA # 61 Neulasta R 61 dasatinib Sprycel ® 61 antibody MT# 61 constipation OIC 61 Panzem ® 61 Rasagiline 61 riociguat 61 TREANDA 61 TBC# 61 cell lymphoma CTCL 61 UPLYSO 61 Esbriet ® 61 RhuDex R 61 oral salmon calcitonin 61 rALLy clinical trial 61 deforolimus 61 Pivotal Phase III 61 plerixafor 61 pan HDAC inhibitor 61 unoprostone isopropyl 61 Zenpep 61 Pegloticase 61 Atypical Hemolytic Uremic Syndrome 61 Ceflatonin ® 61 Eltrombopag 61 severe hypercholesterolemia 61 Orphan Drug 61 haematologic malignancies 61 glucokinase activator 61 intravenous acetaminophen 61 homozygous familial hypercholesterolemia 61 drug ISA# 61 Increlex R 61 TREDAPTIVE 61 oxaliplatin Eloxatin 61 DPP4 inhibitor 61 novel oral anticoagulant 61 ganaxolone 61 PrevOnco 61 denileukin diftitox 60 Hexvix ® 60 myeloproliferative disorders 60 Archexin 60 BAY #-# 60 Tetrabenazine 60 Amigal 60 Bezielle 60 registrational 60 BioNumerik 60 chronic eosinophilic leukemia 60 Orphan Drug designation 60 GATTEX TM 60 R#/MEM 60 IAP inhibitors 60 assessing T DM1 60 CYT# potent vascular disrupting 60 PEGylated interferon beta 1a 60 Ganite R 60 Emezine 60 Allovectin 7 60 Bazedoxifene 60 JAK inhibitor 60 dyskinesia PD LID 60 LEUKINE 60 DDP# 60 sunitinib Sutent 60 GTC recombinant human 60 MYDICAR ® 60 HER2 positive metastatic breast 60 Initiate Clinical Trial 60 RoACTEMRA 60 Zarnestra 60 Xyrem ® 60 erlotinib Tarceva ® 60 Uvidem 60 non nucleoside inhibitor 60 Combidex 60 5 lipoxygenase inhibitor 60 PREOS R 60 Amgen Nplate 60 Cloretazine ® 60 Pirfenidone 60 Trofex 60 SPRYCEL ® 60 AzaSite Plus 60 SANVAR 60 RANK Ligand inhibitor 60 Mipomersen 60 gefitinib Iressa 60 atherothrombotic events 60 Angiox R 60 Akt inhibitor 60 DAVANAT 60 Neulasta ® 60 PKC# 60 OvaRex ® MAb 60 biliary tract cancer 60 formerly LymphoStat B 60 multi kinase inhibitor 60 Vernakalant 60 Cannabinor 60 IV APAP 60 relapsing multiple sclerosis 60 Rhucin R 60 dexpramipexole 60 Cancidas 60 CIMZIA ™ 60 R lenalidomide 60 radiation sensitizer 60 memantine HCl 60 Ophena TM 60 Stedivaze 60 Solasia 60 nucleoside analog 60 pregabalin Lyrica 60 Granted Orphan Drug 60 Naproxcinod 60 Manja Bouman CEO 60 IMiDs 60 exocrine pancreatic insufficiency EPI 60 ACAPODENE 60 diarrhea predominant irritable 60 brivaracetam 60 Tykerb lapatinib 60 subcutaneous formulation 60 Proxinium TM 60 Lodotra 60 Taxotere docetaxel 60 Aplidin R 60 non alcoholic steatohepatitis 60 targeted antifolate 60 investigational therapies 60 TLK# 60 hyaluronidase enzyme 60 BLA filing 60 Plenaxis TM 60 HCD# [002] 60 metastatic colorectal 60 Marketing Authorization Application 60 HoFH 60 HeFH 60 Clofarabine 60 NOX E# 60 GATTEX ™ 60 Pyridorin 60 granulated mesalamine 60 Rhucin ® 60 PF # [002] 60 Soliris TM eculizumab 60 Basilea Toctino R 60 R bendamustine hydrochloride 60 Loramyc R 60 registrational studies 60 Initiates Enrollment 60 Golimumab 60 unresectable liver cancer 60 Urocidin TM 60 Vicinium TM 60 XAGRID 60 Hepatocellular Carcinoma HCC 60 Rebif ® 60 Bendamustine 60 proteasome inhibitor 60 Degarelix 60 ATL# [001] 60 Arimoclomol 60 castrate resistant prostate cancer 60 Alzhemed TM 60 posaconazole 60 IV acetaminophen 60 MKC# MT 60 Irinotecan 60 Dupuytren Contracture 60 NPC 1C 60 gastrointestinal stromal tumors GIST 60 MabCampath 60 Bosutinib 60 RELOVAIR ™ 60 aripiprazole Abilify 60 INCB# [001] 60 Allovectin 7 R 60 Allovectin 7 ® 60 opioid induced constipation 60 psoriasis rheumatoid arthritis 60 postoperative ileus 60 Myocet 60 EOquin 60 eosinophilic asthma 60 anti inflammatory NSAID 60 Huntexil 60 oxypurinol 60 RoActemra 60 Plenaxis R 60 EVIZON TM 60 ponatinib 60 nasal calcitonin product 60 sublingual tablets 60 regadenoson 60 AAG geldanamycin analog 60 Leukine 60 mitogen activated ERK kinase 60 Lp PLA 2 60 cutaneous T cell 60 alemtuzumab Campath 60 Nivestim 60 Eraxis 60 atypical Hemolytic Uremic Syndrome 60 Safinamide 60 Onrigin 60 custirsen 60 osteoarthritis rheumatoid arthritis 60 Clevudine 60 R vitespen 60 NDA Submission 60 IMiD 60 senicapoc 60 IRX 2 60 AVAPRO 60 adalimumab Humira 60 Ixempra 60 SAR# [004] 60 trastuzumab DM1 T DM1 60 induced macular edema 60 chronic myocardial ischemia 60 bardoxolone 60 chronic thromboembolic pulmonary 60 Solazed TM 60 Removab 60 OMAPRO ™ 60 investigational antiplatelet agent 60 standard chemotherapy regimen 60 COLAZAL R 60 Tekamlo 60 metaglidasen 60 Collategene 60 OHR/AVR# 60 eprotirome 60 Zavesca r 60 QNEXA ® 60 tafamidis 60 Hodgkin lymphoma HL 60 metastatic colorectal carcinoma 60 R#/MEM # 60 heterozygous FH 60 selective S#P# receptor agonist 60 HERCEPTIN 60 ruxolitinib 60 Afinitor everolimus 60 GRN# 60 Eprodisate KIACTA TM 59 chronic idiopathic thrombocytopenic purpura 59 Orphan Status 59 opioid induced bowel dysfunction 59 NOXAFIL 59 EnzymeRx 59 Phase #b/#a clinical 59 Brinavess 59 canakinumab 59 Omalizumab 59 enzastaurin 59 PROMACTA 59 Sylvie Gregoire President 59 lumiliximab 59 Torisel temsirolimus 59 Aflibercept 59 Vectibix panitumumab 59 pitavastatin 59 Loramyc 59 oral deforolimus 59 CIMZIA TM certolizumab pegol 59 interferon gamma 1b 59 Guanilib 59 psoriasis Crohn disease 59 VitiGam 59 zileuton 59 EndoTAG TM -1 59 Potelligent Technology 59 SinuNase ™ 59 Li Fraumeni Syndrome 59 Dementia Related Psychosis 59 Intravenous Human 59 ABILIFY ® 59 Saxagliptin 59 ALN PCS 59 Medicinal Products EMEA 59 Meets Primary Endpoint 59 lymphoid malignancies 59 Vascugel 59 Daclizumab 59 fosbretabulin 59 Fibrillex 59 Temsirolimus 59 GATTEX ® 59 Immunotherapeutic 59 Diamyd R 59 Cinquil 59 NV1FGF 59 Excellarate TM 59 subependymal giant cell 59 fipamezole 59 ATPace TM 59 R abatacept 59 Gleevec Glivec 59 Clavis Pharma 59 Omacetaxine 59 LEVADEX ™ 59 Neo Bladder Augment 59 CLARITY study 59 Pazopanib 59 relapsed leukemia 59 Dr. McHutchison 59 Alitretinoin 59 CRMD# 59 dasatinib Sprycel 59 Pemetrexed 59 Lenocta 59 balsalazide tablet 59 Familial Adenomatous Polyposis FAP 59 Zavesca R 59 SAR# [002] 59 PREOS 59 QNEXA 59 Genentech Rituxan 59 human C1 inhibitor 59 CINOD 59 lorcaserin Phase 59 Phase IIb clinical trials 59 Santhera 59 BEXXAR 59 MPS VI 59 thymalfasin 59 PEG SN# 59 ARIXTRA 59 topically applied SEPA 59 NP2 Enkephalin 59 vinca alkaloid 59 Maribavir 59 WILEX 59 Liprostin 59 Marketing Authorisation 59 Alvesco R 59 MOVIPREP R 59 Enzyme Replacement Therapy 59 panitumumab Vectibix 59 Cutaneous T 59 de novo kidney transplant 59 polycythemia vera essential thrombocythemia 59 monoclonal anti 59 Xelox 59 Aurexis 59 Azilect ® 59 Vimpat ® lacosamide 59 Androxal TM 59 paclitaxel Taxol ® 59 cediranib 59 human antithrombin 59 OZURDEX ® 59 PSN# [002] 59 incyclinide 59 Nexavar tablets 59 ALN TTR# 59 ATG Fresenius S 59 OMNARIS HFA 59 Aceon 59 Orphan Drug Status 59 Atrasentan 59 % uracil topical 59 GLPG# 59 oral methylnaltrexone 59 metastatic hormone refractory 59 arthritis PsA 59 cisplatin gemcitabine 59 Sudhir Agrawal D.Phil 59 Drug Eluting Stent System 59 orally inhaled migraine 59 Ilaris 59 oral FTY# 59 JAK inhibitors 59 Nimotuzumab 59 Biologic License Application BLA 59 samarium Sm 59 amifampridine phosphate 59 Dual Opioid 59 Orathecin 59 THALOMID ® 59 Urocidin 59 Spiegelmer ® 59 Nanobody 59 Zavesca 59 ALN HPN 59 topical NSAID 59 gastrointestinal stromal tumors 59 CIMZIA TM 59 Benlysta belimumab 59 DP b# 59 Perforomist ™ Inhalation Solution 59 Iloperidone 59 ARIKACE ™ 59 OncoVex 59 tubulin inhibitor 59 delivers fluocinolone acetonide FA 59 P#X# antagonist 59 prucalopride 59 Ventavis 59 Kamada AAT 59 Oral NKTR 59 tiuxetan 59 pegfilgrastim 59 highly selective adenosine 59 Romidepsin 59 Tracleer ® bosentan 59 PEGylated Fab fragment 59 BrachySil TM 59 Orphan Designation 59 STELARA TM 59 octreotide acetate 59 CCX# 59 lorvotuzumab mertansine 59 SomatoKine 59 Mirapexin 59 Bayer Nexavar 59 Revlimid lenalidomide 59 Orally administered 59 vinflunine 59 Catena ® 59 Trandolapril 59 Eloxatin ® 59 CAPHOSOL R 59 talactoferrin 59 maribavir 59 LymphoStat B belimumab 59 Zolinza 59 Muraglitazar 59 multicenter Phase III 59 Tamibarotene 59 HepeX B TM 59 Rilonacept 59 TRX1 59 dosing cohort 59 oral ghrelin agonist 59 metastatic bladder 59 SYN# 59 Rhucin ® recombinant 59 phase IIb clinical 59 refractory angina 59 Phase 2a clinical trials 59 Orencia abatacept 59 DepoDur 59 Quinamed 59 romidepsin 59 mTOR inhibitor 59 arsenic trioxide injection 59 Tacrolimus 59 Zemiva TM 59 AstraZeneca Symbicort 59 HGS# 59 peripherally acting 59 novel synthetic PEGylated 59 bortezomib Velcade R 59 evaluating satraplatin 59 myeloproliferative diseases 59 lintuzumab SGN 59 Natalizumab 59 casopitant 59 Morquio 59 ADVEXIN 59 investigational hepatitis C 59 Argatroban 59 GED aPC 59 Receives Marketing Authorization 59 cardio renal 59 atypical antipsychotic medication 59 Tracleer r 59 Xerecept 59 cetuximab Erbitux ® 59 lenalidomide Revlimid R 59 Arcalyst 59 dual endothelin receptor antagonist 59 Hexvix 59 MT#/MEDI-# 59 Rhucin 59 Fondaparinux 59 NEUPREX R 59 FUSILEV ® 59 Ecallantide 59 inhaled AAT 59 ATryn ® GTC recombinant 59 anti fibrotic 59 6R BH4 59 Sym# 59 investigational pharmacologically unique 59 Symadex 59 NXL# 59 neurogenic orthostatic hypotension 59 pancreatic enzyme replacement 59 ILUVIEN ® 59 XIAPEX ® 59 post menopausal osteoporosis 59 SinuNase TM 59 refractory APL 59 Etanercept 59 ELIQUIS 59 REMICADE infliximab 59 oxymorphone ER 59 KIACTA ™ 59 including eniluracil ADH 59 ORENCIA ® 59 Modrenal R 59 Rituxan rituximab 59 tanespimycin 59 abatacept Orencia 59 lixivaptan 59 ONCONASE R 59 Zingo TM 59 ISIS # 59 sapropterin dihydrochloride 59 investigational monoclonal antibody 59 paclitaxel poliglumex 59 systemic lupus erythematosus 59 metastatic GIST 59 phase IIa clinical 59 huC# DM4 59 Dalbavancin 58 FACTIVE R gemifloxacin 58 Hycamtin 58 XIAPEX 58 bladder ovarian 58 Marketing Authorization Applications 58 ZACTIMA 58 Bayer Onyx 58 personalized cellular immunotherapy 58 tramiprosate Alzhemed TM 58 Amplimexon 58 Alvesco ® 58 Ataluren 58 cannabinor 58 romiplostim 58 Apaziquone 58 Zytiga 58 BRAF inhibitor 58 ATryn ® 58 Nexavar prescribing 58 Cinryze ™ 58 ONTAK 58 Entereg R 58 THALOMID 58 vitreoretinal disorders 58 Diabetic Macular Edema 58 Inhalation Solution 58 MAXY alpha 58 idiopathic thrombocytopenic purpura ITP 58 therapeutically inactive prodrug 58 lomitapide 58 PNT# 58 darapladib 58 CardioFit 58 ENMD # 58 autologous cellular immunotherapy 58 TheraCIM 58 BRAF V# mutation 58 lucinactant 58 MKC# MKC# PP 58 Sanvar R 58 RELISTOR ® 58 HepaGam B TM 58 mifamurtide 58 benign prostatic hypertrophy BPH 58 telomerase therapeutic 58 ZADAXIN ® 58 torsemide ER 58 inhalation powder 58 pharmacological chaperone 58 eniluracil 58 REBETOL combination therapy 58 multicenter Phase II 58 AQ4N 58 regorafenib 58 dirucotide MBP# 58 FASLODEX 58 recurrent herpes labialis 58 inhaled formulation 58 Cimzia R 58 Application MAA 58 patientswith 58 Toctino ® alitretinoin 58 colorectal carcinoma 58 urocortin 2 58 Gentamicin Surgical Implant 58 telaprevir VX 58 Celebrex celecoxib 58 MEPACT 58 Systemic Lupus Erythematosus SLE 58 refractory Hodgkin lymphoma 58 papillary renal cell carcinoma 58 phase Ib 58 Hypertriglyceridemia 58 investigational atypical antipsychotic 58 BCG refractory carcinoma 58 Nipent R 58 apoptosis proteins 58 PhotoCure 58 daclizumab 58 pentostatin 58 paclitaxel Taxol R 58 Q#IR 58 TOLAMBA 58 HepaSphere 58 Ostarine ™ 58 Genz # 58 INCB# [003] 58 TroVax ® 58 Mimpara R 58 tramiprosate ALZHEMED TM 58 chronic granulomatous disease 58 LibiGel ® 58 ocular formulation 58 Phase III Clinical Trial 58 Lodotra TM 58 VALSTAR 58 cetuximab Erbitux R 58 LUCASSIN